378 related articles for article (PubMed ID: 24946724)
1. Assessment of immunogenic characteristics of Hemiscorpius lepturus venom and its cross-reactivity with venoms from Androctonus crassicauda and Mesobuthus eupeus.
Khanbashi S; Khodadadi A; Assarehzadegan MA; Pipelzadeh MH; Vazirianzadeh B; Hosseinzadeh M; Rahmani AH; Asmar A
J Immunotoxicol; 2015; 12(3):217-22. PubMed ID: 24946724
[TBL] [Abstract][Full Text] [Related]
2. An in vitro comparative study upon the toxic properties of the venoms from Hemiscorpius lepturus, Androctonus crassicauda and Mesobuthus eupeus scorpions.
Khodadadi A; Pipelzadeh MH; Vazirianzadeh B; Pipelzadeh M; Sharifat M
Toxicon; 2012 Sep; 60(3):385-90. PubMed ID: 22569320
[TBL] [Abstract][Full Text] [Related]
3. The neutralizing capacity of Androctonus crassicauda antivenom against Mesobuthus eupeus scorpion venom.
Ozkan O; Carhan A
Toxicon; 2008 Aug; 52(2):375-9. PubMed ID: 18625264
[TBL] [Abstract][Full Text] [Related]
4. Heminecrolysin, a potential immunogen for monospecific antivenom production against Hemiscorpius lepturus scorpion.
Borchani L; Sassi A; Ben Yekhlef R; Safra I; El Ayeb M
Toxicon; 2011 Dec; 58(8):681-8. PubMed ID: 21967811
[TBL] [Abstract][Full Text] [Related]
5. Serum TNF-α levels reflect the clinical severity of envenomation following a Hemiscorpius lepturus sting.
Jalali A; Pipelzadeh MH; Taraz M; Khodadadi A; Makvandi M; Rowan EG
Eur Cytokine Netw; 2011 Mar; 22(1):5-10. PubMed ID: 21411417
[TBL] [Abstract][Full Text] [Related]
6. Identification of the immunogenic epitopes of the whole venom component of the Hemiscorpius lepturus scorpion using the phage display peptide library.
Jahdasani R; Jamnani FR; Behdani M; Habibi-Anbouhi M; Yardehnavi N; Shahbazzadeh D; Kazemi-Lomedasht F
Toxicon; 2016 Dec; 124():83-93. PubMed ID: 27845058
[TBL] [Abstract][Full Text] [Related]
7. Introducing Compsobuthus matthiesseni (Birula, 1905) scorpion as one of the major stinging scorpions in Khuzestan, Iran.
Dehghani R; Djadid ND; Shahbazzadeh D; Bigdelli S
Toxicon; 2009 Sep; 54(3):272-5. PubMed ID: 19393258
[TBL] [Abstract][Full Text] [Related]
8. The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus.
Kazemi-Lomedasht F; Khalaj V; Bagheri KP; Behdani M; Shahbazzadeh D
Toxicon; 2017 Jan; 125():123-130. PubMed ID: 27914888
[TBL] [Abstract][Full Text] [Related]
9. Developing recombinant phospholipase D1 (rPLD1) toxoid from Iranian Hemiscorpius lepturus scorpion and its protective effects in BALB/c mice.
Safari Foroushani N; Modarressi MH; Behdani M; Torabi E; Pooshang Bagheri K; Shahbazzadeh D
Toxicon; 2018 Sep; 152():30-36. PubMed ID: 29981815
[TBL] [Abstract][Full Text] [Related]
10. Neutralization Capacity of Monovalant Antivenom Against Existing Lethal Scorpions in the Turkish Scorpiofauna.
Ozkan O; Yağmur EA
Iran J Pharm Res; 2017; 16(2):653-660. PubMed ID: 28979319
[TBL] [Abstract][Full Text] [Related]
11. General characterization of Tityus fasciolatus scorpion venom. Molecular identification of toxins and localization of linear B-cell epitopes.
Mendes TM; Guimarães-Okamoto PT; Machado-de-Avila RA; Oliveira D; Melo MM; Lobato ZI; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2015 Jun; 99():109-17. PubMed ID: 25817000
[TBL] [Abstract][Full Text] [Related]
12. A. crassicauda, M. eupeus and H. lepturus scorpion venoms initiate a strong in vivo anticancer immune response in CT26-tumor mice model.
Amirgholami N; Karampour NS; Ghadiri A; Tagavi Moghadam A; Ghasemi Dehcheshmeh M; Pipelzadeh MH
Toxicon; 2020 Jun; 180():31-38. PubMed ID: 32275983
[TBL] [Abstract][Full Text] [Related]
13. An equilibrium ELISA for the dosage of Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpion venoms: set up and calibration.
Krifi MN; el Ayeb M
Arch Inst Pasteur Tunis; 1998; 75(3-4):185-94. PubMed ID: 14666744
[TBL] [Abstract][Full Text] [Related]
14. Complete neutralization of the lethality of Hemiscorpius lepturus crude venom by a novel anti-recombinant phospholipase D1 IgGs.
Torabi E; Behdani M; Khalaj V; Pooshang Bagheri K; Shahbazzadeh D
Toxicon; 2020 Aug; 183():36-43. PubMed ID: 32445840
[TBL] [Abstract][Full Text] [Related]
15. Pioneering Study on
Abreu CB; Bordon KCF; Cerni FA; Oliveira IS; Balenzuela C; Alexandre-Silva GM; Zoccal KF; Reis MB; Wiezel GA; Peigneur S; Pinheiro-Júnior EL; Tytgat J; Cunha TM; Quinton L; Faccioli LH; Arantes EC; Zottich U; Pucca MB
Front Immunol; 2020; 11():2011. PubMed ID: 32973807
[TBL] [Abstract][Full Text] [Related]
16. Scorpion sting in Iran: a review.
Dehghani R; Fathi B
Toxicon; 2012 Oct; 60(5):919-33. PubMed ID: 22750221
[TBL] [Abstract][Full Text] [Related]
17. Androctonus crassicauda (Olivier), a dangerous and unduly neglected scorpion--I. Pharmacological and clinical studies.
Ismail M; Abd-Elsalam MA; al-Ahaidib MS
Toxicon; 1994 Dec; 32(12):1599-618. PubMed ID: 7725329
[TBL] [Abstract][Full Text] [Related]
18. Novel Mutant Phospholipase D from
Soleimani Moez A; H Sajedi R; Pooshang Bagheri K; Sabatier JM; Shahbazzadeh D
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260428
[No Abstract] [Full Text] [Related]
19. New and safe formulation for scorpion immunotherapy: Comparative study between saponin and FCA adjuvants associated to attenuated venom.
Nouri A; Nait Mohamed FA; Laraba-Djebari F
Vaccine; 2018 Mar; 36(13):1720-1727. PubMed ID: 29483031
[TBL] [Abstract][Full Text] [Related]
20. Scorpion stings in Turkey: epidemiological and clinical aspects between the years 1995 and 2004.
Cesaretli Y; Ozkan O
Rev Inst Med Trop Sao Paulo; 2010; 52(4):215-20. PubMed ID: 21748231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
